Moreover, use of ACE-1 inhibitors and angiotensin receptor blockers may affect COVID-19 through modulating levels of Angiotensin-converting enzyme 2 (ACE-2; EC 3.4.17.23), the cell entry receptor for SARS-CoV2 [15]. Here, ACE2 is linked to COVID-19.